NASDAQ| TSX: ACB
European grant advances Aurora's unparalleled leadership in cannabis genetics, enhancing its position as a leading medical cannabis company
Read more at newswire.caAurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.